Literature DB >> 10699177

Cell cycle-dependent phosphorylation of the ATRX protein correlates with changes in nuclear matrix and chromatin association.

N G Bérubé1, C A Smeenk, D J Picketts.   

Abstract

Mutations in the ATRX gene are associated with an X-linked mental retardation (XLMR) syndrome most often accompanied by alpha-thalassaemia (ATR-X syndrome). The ATRX gene encodes a predicted protein of 280 kDa featuring a PHD zinc finger motif and an ATPase/helicase domain of the SWI/SNF type; the vast majority of mutations in the ATRX gene fall within these two motifs. Although these domains are suggestive of a role for ATRX in transcriptional regulation by affecting chromatin structure and/or function, the precise cellular role of the ATRX protein remains undefined. Using indirect immunofluorescence and biochemical fractionation, we demonstrate that the ATRX protein has a punctate nuclear staining pattern and that it is tightly associated with the nuclear matrix at interphase. At the onset of M phase, the ATRX protein was associated mainly with condensed chromatin. The association of the ATRX protein with chromosomes at mitosis is concomitant with phosphorylation of the protein and its association with heterochromatin protein 1alpha (HP1alpha). The phosphorylation-dependent changes in localization between the nuclear matrix and condensed chromatin are consistent with a dual role for ATRX, possibly involving gene regulation at interphase and chromosomal segregation at mitosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10699177     DOI: 10.1093/hmg/9.4.539

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  54 in total

1.  Mitotic partitioning and selective reorganization of tissue-specific transcription factors in progeny cells.

Authors:  Sayyed K Zaidi; Daniel W Young; Shirwin M Pockwinse; Amjad Javed; Jane B Lian; Janet L Stein; Andre J van Wijnen; Gary S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

2.  The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies.

Authors:  Yutong Xue; Richard Gibbons; Zhijiang Yan; Dafeng Yang; Tarra L McDowell; Salvatore Sechi; Jun Qin; Sharleen Zhou; Doug Higgs; Weidong Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-02       Impact factor: 11.205

3.  Association of Lsh, a regulator of DNA methylation, with pericentromeric heterochromatin is dependent on intact heterochromatin.

Authors:  Qingsheng Yan; Edward Cho; Stephen Lockett; Kathrin Muegge
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

4.  ATRX-mediated chromatin association of histone variant macroH2A1 regulates α-globin expression.

Authors:  Kajan Ratnakumar; Luis F Duarte; Gary LeRoy; Dan Hasson; Daniel Smeets; Chiara Vardabasso; Clemens Bönisch; Tianying Zeng; Bin Xiang; David Y Zhang; Haitao Li; Xiaowo Wang; Sandra B Hake; Lothar Schermelleh; Benjamin A Garcia; Emily Bernstein
Journal:  Genes Dev       Date:  2012-03-01       Impact factor: 11.361

5.  CTCF binding and higher order chromatin structure of the H19 locus are maintained in mitotic chromatin.

Authors:  Les J Burke; Ru Zhang; Marek Bartkuhn; Vijay K Tiwari; Gholamreza Tavoosidana; Sreenivasulu Kurukuti; Christine Weth; Joerg Leers; Niels Galjart; Rolf Ohlsson; Rainer Renkawitz
Journal:  EMBO J       Date:  2005-08-18       Impact factor: 11.598

6.  Molecular basis of cellular localization of poly C binding protein 1 in neuronal cells.

Authors:  Andrea M Berry; Kelly E Flock; Horace H Loh; Jane L Ko
Journal:  Biochem Biophys Res Commun       Date:  2006-09-12       Impact factor: 3.575

7.  A diagnosis of discernment: Identifying a novel ATRX mutation in myelodysplastic syndrome with acquired α-thalassemia.

Authors:  Jedrzej Wykretowicz; Yeohan Song; Brooke McKnight; Sung Won Choi; John Magenau; Radhika Takiar; Paul El Tomb; David Ginsburg; Dale Bixby; Rami Khoriaty
Journal:  Cancer Genet       Date:  2019-01-09

Review 8.  Mutant ATRX: uncovering a new therapeutic target for glioma.

Authors:  Santiago Haase; María Belén Garcia-Fabiani; Stephen Carney; David Altshuler; Felipe J Núñez; Flor M Méndez; Fernando Núñez; Pedro R Lowenstein; Maria G Castro
Journal:  Expert Opin Ther Targets       Date:  2018-06-20       Impact factor: 6.902

9.  Effects of trichostatin A on neuronal mu-opioid receptor gene expression.

Authors:  Ying-Chih Lin; Kelly E Flock; Ryan J Cook; Amanda J Hunkele; Horace H Loh; Jane L Ko
Journal:  Brain Res       Date:  2008-10-11       Impact factor: 3.252

Review 10.  ATRX: the case of a peculiar chromatin remodeler.

Authors:  Kajan Ratnakumar; Emily Bernstein
Journal:  Epigenetics       Date:  2012-12-18       Impact factor: 4.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.